Back/Modular, connected UV curing platform draws interest from medical-device firms like Beyond Air
tech·February 16, 2026·xair

Modular, connected UV curing platform draws interest from medical-device firms like Beyond Air

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • APS’s UV XAIR design trends attract medical-device makers, including Beyond Air.
  • Beyond Air (portable inhaled therapeutics) needs robust remote support and low field maintenance for continuous patient access.
  • Connectivity integration helps Beyond Air enable remote monitoring, streamlined field service, and faster paths to clinical benefit.

Connected, modular device design that lowers downtime draws attention from medical device firms such as Beyond Air

Modular, connected platforms reshaping device adoption

American Pipelining Solutions (APS) is rolling out the UV XAIR, a compact ultraviolet curing system for small-diameter trenchless pipe relining that exemplifies device-design trends now drawing interest from medical-device makers including Beyond Air. The UV XAIR pairs a single light head that cures 3- to 24-inch pipes with wireless tablet control, cloud-based data management and field-replaceable components, aiming to reduce on-site downtime and ownership costs. For respiratory-device companies, those same attributes — single-platform versatility, remote software updates, cloud reporting and easy parts replacement — translate into faster deployment, lower service burden and tighter clinical or operational oversight.

Beyond Air, which develops portable inhaled therapeutics, shares industry incentives with trenchless-equipment suppliers: devices used in distributed settings require robust remote support and minimal field maintenance to ensure continuous patient access. APS’s emphasis on automatic updates, built-in WiFi tech support and a complete aftermarket parts kit reinforces a model of product-as-platform that medical-device firms emulate as they scale training, regulatory compliance and post-market surveillance. APS CEO Jake Saltzman frames the product as delivering “speed, control and performance,” a language that mirrors priorities in ambulatory respiratory care where uptime and reliable data capture affect outcomes and reimbursement.

The UV XAIR example also highlights how cross-industry advances in connectivity and modularity can accelerate adoption. Cloud-managed reporting and tablet interfaces simplify operator training and create auditable records — features that are increasingly required by regulators and health systems. For Beyond Air and peers, integrating these capabilities into therapy-delivery systems supports remote monitoring, streamlines field service and potentially shortens the path from device deployment to measurable clinical benefit.

Partnerships and market positioning

APS introduces the UV XAIR through partnerships with SacPro and UV Relining, and plans to debut the system at the WWETT Show in Indianapolis (Booth 3104) in February 2026. SacPro’s CEO Fredrik Sterner highlights junction and patching capabilities as creating efficiency and safety gains for U.S. plumbing contractors.

Service, training and ecosystem play

Based in Anderson, South Carolina, APS pairs the UV XAIR with existing CIPP liners, resin, inspection tools and training programs to deliver an end-to-end offering. The company says the launch, announced via PR Newswire on Feb. 13, 2026, strengthens its North American market position by reducing project turnaround and equipment downtime through aftermarket parts availability and field support.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...